Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2021-09-21 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −10,000 56,900
2021-09-20 Martin Michael Robert Chief Business Officer Option exercise +28,500 $5.30 $151K 205,361
2021-09-20 Martin Michael Robert Chief Business Officer Sale −12,500 $21.71 $271K 192,861
2021-09-20 Martin Michael Robert Chief Business Officer Sale −16,000 $21.60 $346K 176,861
2021-09-20 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −28,500 $5.30 $151K 7,500
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise +44,000 $5.30 $233K 220,861
2021-09-14 Martin Michael Robert Chief Business Officer Sale −14,000 $21.73 $304K 206,861
2021-09-14 Martin Michael Robert Chief Business Officer Sale −30,000 $21.80 $654K 176,861
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −44,000 36,000
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise +45,000 $5.30 $239K 221,861
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise +45,000 $3.20 $144K 266,861
2021-09-14 Martin Michael Robert Chief Business Officer Sale −90,000 $21.19 $1.9M 176,861
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −45,000 80,000
2021-09-14 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −45,000 45,000
2021-09-14 Huizinga Robert Bindert EVP of Research Sale −22,500 $21.75 $489K 106,092
2021-09-13 Martin Michael Robert Chief Business Officer Option exercise +25,000 $5.30 $133K 201,861
2021-09-13 Martin Michael Robert Chief Business Officer Option exercise · Option Grant (right to buy) −25,000 125,000
2021-09-13 Solomons Neil Chief Medical Officer Option exercise +150,000 $3.20 $480K 287,299
2021-09-13 Solomons Neil Chief Medical Officer Option exercise · Stock Option (right to buy) −150,000 2,000
2021-09-10 Martin Michael Robert Chief Business Officer Sale −25,000 $19.80 $495K 176,861

Page 15 of 18 · 345 trades